Loading provider…
Loading provider…
Transplant Surgery Physician in Duarte, CA
NPI: 1538217435Primary Employer
Southern California Permanente Medical Group
healthy.kaiserpermanente.org
HQ Phone
Get MD Firoozeh's Phone Numberphone_androidMobile
Get MD Firoozeh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
Authors: Sahebi, Firoozeh, Iacobelli, Simona, Sbianchi, Giulia, Koster, Linda, Blaise, Didier, Reményi, Péter, Russell, Nigel H, Ljungman, Per, Kobbe, Guido, Apperley, Jane, Trneny, Marek, Krejci, Marta, Wiktor-Jedrzejczak, Wieslaw, Sanchez, James F, Schaap, Nicolaas, Isaksson, Cecilia, Lenhoff, Stig, Browne, Paul, Scheid, Christof, Wilson, Keith M O, Yakoub-Agha, Ibrahim, Muñiz, Soledad González, Schönland, Stefan, Morris, Curly, Garderet, Laurent, Kröger, Nicolaus
Journal: Biol Blood Marrow Transplant
Publication Date: 2018-01-12
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
Authors: Peter Mcsweeney, Amelia Langston, Michael Pulsipher, Marco Mielcarek, Benedetto Bruno, Andrew Yeager, Edward Agura
Publication Date: 2011-11-03
Authors: Joo Song, Jeffrey Wong, Pablo Parker, Stephen Forman, George Somlo, Ricardo Spielberger, Colton Ladbury, Leslie Popplewell, David Snyder
Journal: Transplant Cell Ther
Publication Date: 2022-05-06
Lead Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: laboratory biomarker analysis, DRUG: bortezomib, PROCEDURE: peripheral blood stem cell transplantation, DRUG: sirolimus, DRUG: tacrolimus, RADIATION: total marrow irradiation, DRUG: fludarabine phosphate, OTHER: melphalan
Lead Sponsor: Washington University School of Medicine
Collaborators: Millennium Pharmaceuticals, Inc., Multiple Myeloma Research Consortium
Intervention / Treatment: DRUG: Lenalidomide, DRUG: Dexamethasone, BIOLOGICAL: Ixazomib